Targeting KRAS G12D: VS-7375 Shows Tumor Shrinkage in Early Pancreatic Cancer Trial
Among 22 previously treated patients with metastatic pancreatic cancer, 9 had confirmed tumor responses. These preliminary data offer clues for a precision-targeted strategy, but larger controlled trials are still needed to determine whether it can extend survival.